NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3X ETF (LABD) Price, Holdings, & News $9.11 +0.70 (+8.32%) Closing price 11/20/2026 04:10 PM EasternExtended Trading$8.94 -0.16 (-1.81%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnership About Direxion Daily S&P Biotech Bear 3X ETF (NYSEARCA:LABD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABD alerts:Sign Up Key Stats Today's Range$8.18▼$9.1650-Day Range$6.51▼$9.1152-Week Range$5.81▼$27.22Volume19.34 million shsAverage Volume11.91 million shsMarket Capitalization$77.07 millionAssets Under Management$67.88 millionDividend Yield5.05%Net Expense Ratio1.07%Aggregate RatingN/A ETF Overview The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bear 3X ETF ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.55%0.57%0.50%0.53%Other Expenses0.33%0.52%0.53%0.60%0.54%Total Expense1.08%0.76%0.75%0.75%0.73%Fee Waiver-0.01%-0.85%-0.67%-0.76%-0.67%Net Expense1.07%0.58%0.63%0.57%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3X ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABD ETF News HeadlinesDirexion Daily SP Biotech Bear 3X (LABD)October 16, 2026 | es.investing.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0707September 22, 2026 | msn.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 22 at 1:00 AM | Base Camp Trading (Ad)Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0707September 22, 2026 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0752June 23, 2026 | msn.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0853March 26, 2026 | msn.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3X ETF's stock was trading at $21.06 at the beginning of 2026. Since then, LABD shares have decreased by 56.7% and is now trading at $9.11. When did Direxion Daily S&P Biotech Bear 3X ETF's stock split? Direxion Daily S&P Biotech Bear 3X ETF's stock reverse split before market open on Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bear 3X ETF's major shareholders? Top institutional investors of Direxion Daily S&P Biotech Bear 3X ETF include Jump Financial LLC (5.51%) and Goldman Sachs Group Inc. (1.46%). How do I buy shares of Direxion Daily S&P Biotech Bear 3X ETF? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3X ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3X ETF investors own include Direxion Daily S&P Biotech Bull 3X ETF (LABU), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), AT&T (T), Direxion Daily Energy Bull 2X ETF (ERX) and Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF (GUSH). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3X ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Constituents21 Fund Statistics Assets Under Management$67.88 million Average Daily Volume$0.00 Discount/Premium0.00% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1,319 Put Options379 Call Options940 Short Interest2,090,000 shs Miscellaneous Outstanding Shares8,460,000Beta-2.51 Creation Unit50,000 Creation Fee$250.00 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report Top 10 LABD HoldingsGOLDMAN FINL SQ TRSRY INST 506Holding Weight: 52.35%DREYFUS GOVT CASH MAN INSHolding Weight: 36.88%GOLDMAN SACHS FIN GOV 465 INSTITUTHolding Weight: 18.59%DREYFUS TRSRY SECURITIES CASH MGMTHolding Weight: 3.88%SPSIBI SWAP ASSET LEGHolding Weight: -1.92%SPSIBI SWAP ASSET LEGHolding Weight: -6.11%SPSIBI SWAP ASSET LEGHolding Weight: -19.67%SPSIBI SWAP ASSET LEGHolding Weight: -59.64%SPSIBI SWAP ASSET LEGHolding Weight: -64.33%SPSIBI SWAP ASSET LEGHolding Weight: -148.32%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredA quick test most investors failCan you defend your biggest holding? Seeking Alpha Premium gives you its Quant valuation grade versus its sect...Seeking Alpha | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3X ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3X ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.